Literature DB >> 23740975

Topological analysis of HIV-1 glycoproteins expressed in situ on virus surfaces reveals tighter packing but greater conformational flexibility than for soluble gp120.

Tommy Tong1, Keiko Osawa, James E Robinson, Ema T Crooks, James M Binley.   

Abstract

In natural infection, antibodies interact with HIV-1 primarily through nonfunctional forms of envelope glycoproteins (Env), including uncleaved (UNC) gp160 and gp41 stumps. These antigens are important to fully characterize, as they may be decoys that promote nonneutralizing responses and may also be targets for nonneutralizing effector responses. In this study, we compared the antigenic properties of Env expressed in situ on pseudovirion virus-like particle (VLP) surfaces and soluble gp120 using harmonized enzyme-linked immunosorbent assays (ELISAs) and a panel of 51 monoclonal antibodies (MAbs). Only 32 of 46 soluble gp120-reactive MAbs recognized the primary UNC gp160 antigen of VLPs. Indeed, many epitopes were poorly exposed (C1, V2, C1-C4, C4, C4-V3, CD4 induced [CD4i], and PGT group 3) or obscured (C2, C5, and C1-C5) on VLPs. In further studies, VLP Env exhibited an increased degree of inter-MAb competition, the epicenter of which was the base of the V3 loop, where PGT, 2G12, V3, and CD4 binding site specificities competed. UNC gp160 also underwent more drastic soluble CD4 (sCD4)-induced conformational changes than soluble gp120, exposing CD4i, C1-C4, and V2 epitopes. A greater propensity of UNC gp160 to undergo conformational changes was also suggested by the induction of CD4i MAb binding to VLPs by a V3 MAb as well as by soluble CD4. The same effect was not observed for soluble gp120. Taken together, our data suggest that membrane-expressed UNC gp160 exists in a less "triggered" conformational state than soluble gp120 and that MAb binding to UNC gp160 tends to have greater conformational consequences.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740975      PMCID: PMC3754051          DOI: 10.1128/JVI.01145-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  96 in total

1.  HIV-1 neutralization coverage is improved by combining monoclonal antibodies that target independent epitopes.

Authors:  Nicole A Doria-Rose; Mark K Louder; Zhongjia Yang; Sijy O'Dell; Martha Nason; Stephen D Schmidt; Krisha McKee; Michael S Seaman; Robert T Bailer; John R Mascola
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

2.  HIV-1 virus-like particles bearing pure env trimers expose neutralizing epitopes but occlude nonneutralizing epitopes.

Authors:  Tommy Tong; Ema T Crooks; Keiko Osawa; James M Binley
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

3.  Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody.

Authors:  Dennis R Burton; Ann J Hessell; Brandon F Keele; Per Johan Klasse; Thomas A Ketas; Brian Moldt; D Cameron Dunlop; Pascal Poignard; Lara A Doyle; Lisa Cavacini; Ronald S Veazey; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

4.  Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity.

Authors:  B K Chakrabarti; L M Walker; J F Guenaga; A Ghobbeh; P Poignard; D R Burton; R T Wyatt
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

5.  Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01.

Authors:  Yuxing Li; Sijy O'Dell; Laura M Walker; Xueling Wu; Javier Guenaga; Yu Feng; Stephen D Schmidt; Krisha McKee; Mark K Louder; Julie E Ledgerwood; Barney S Graham; Barton F Haynes; Dennis R Burton; Richard T Wyatt; John R Mascola
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

Review 6.  HIV vaccine development at the turn of the 21st century.

Authors:  Marc P Girard; Stanley A Plotkin
Journal:  Curr Opin HIV AIDS       Date:  2012-01       Impact factor: 4.283

7.  An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum.

Authors:  Guido Ferrari; Justin Pollara; Daniel Kozink; Tiara Harms; Mark Drinker; Stephanie Freel; M Anthony Moody; S Munir Alam; Georgia D Tomaras; Christina Ochsenbauer; John C Kappes; George M Shaw; James A Hoxie; James E Robinson; Barton F Haynes
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

8.  The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.

Authors:  Camille Bonomelli; Katie J Doores; D Cameron Dunlop; Victoria Thaney; Raymond A Dwek; Dennis R Burton; Max Crispin; Christopher N Scanlan
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

9.  Functional stability of unliganded envelope glycoprotein spikes among isolates of human immunodeficiency virus type 1 (HIV-1).

Authors:  Nitish Agrawal; Daniel P Leaman; Eric Rowcliffe; Heather Kinkead; Raman Nohria; Junya Akagi; Katherine Bauer; Sean X Du; Robert G Whalen; Dennis R Burton; Michael B Zwick
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

10.  Broad neutralization coverage of HIV by multiple highly potent antibodies.

Authors:  Laura M Walker; Michael Huber; Katie J Doores; Emilia Falkowska; Robert Pejchal; Jean-Philippe Julien; Sheng-Kai Wang; Alejandra Ramos; Po-Ying Chan-Hui; Matthew Moyle; Jennifer L Mitcham; Phillip W Hammond; Ole A Olsen; Pham Phung; Steven Fling; Chi-Huey Wong; Sanjay Phogat; Terri Wrin; Melissa D Simek; Wayne C Koff; Ian A Wilson; Dennis R Burton; Pascal Poignard
Journal:  Nature       Date:  2011-09-22       Impact factor: 49.962

View more
  10 in total

1.  Effects of partially dismantling the CD4 binding site glycan fence of HIV-1 Envelope glycoprotein trimers on neutralizing antibody induction.

Authors:  Ema T Crooks; Keiko Osawa; Tommy Tong; Samantha L Grimley; Yang D Dai; Robert G Whalen; Daniel W Kulp; Sergey Menis; William R Schief; James M Binley
Journal:  Virology       Date:  2017-03-06       Impact factor: 3.616

2.  Multi-Parameter Exploration of HIV-1 Virus-Like Particles as Neutralizing Antibody Immunogens in Guinea Pigs, Rabbits and Macaques.

Authors:  Tommy Tong; Ema T Crooks; Keiko Osawa; James E Robinson; Mary Barnes; Cristian Apetrei; James M Binley
Journal:  Virology       Date:  2014-05       Impact factor: 3.616

3.  Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.

Authors:  Seth H Pincus; Kejing Song; Grace A Maresh; Dean H Hamer; Dimiter S Dimitrov; Weizao Chen; Mei-Yun Zhang; Victor F Ghetie; Po-Ying Chan-Hui; James E Robinson; Ellen S Vitetta
Journal:  J Virol       Date:  2017-01-18       Impact factor: 5.103

4.  Cleavage strongly influences whether soluble HIV-1 envelope glycoprotein trimers adopt a native-like conformation.

Authors:  Rajesh P Ringe; Rogier W Sanders; Anila Yasmeen; Helen J Kim; Jeong Hyun Lee; Albert Cupo; Jacob Korzun; Ronald Derking; Thijs van Montfort; Jean-Philippe Julien; Ian A Wilson; Per Johan Klasse; Andrew B Ward; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

5.  HIV Envelope gp120 Alters T Cell Receptor Mobilization in the Immunological Synapse of Uninfected CD4 T Cells and Augments T Cell Activation.

Authors:  Jing Deng; Yu-Ya Mitsuki; Guomiao Shen; Jocelyn C Ray; Claudia Cicala; James Arthos; Michael L Dustin; Catarina E Hioe
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

6.  Cross-Neutralizing CRF01_AE-Infected Plasma from Malaysia Targets CD4-Binding Site of Human Immunodeficiency Virus Type-1 Envelope Glycoprotein.

Authors:  Qi Ron Ng; Kok Keng Tee; James M Binley; Tommy Tong
Journal:  AIDS Res Hum Retroviruses       Date:  2021-06-17       Impact factor: 1.723

7.  Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site.

Authors:  Ema T Crooks; Tommy Tong; Bimal Chakrabarti; Kristin Narayan; Ivelin S Georgiev; Sergey Menis; Xiaoxing Huang; Daniel Kulp; Keiko Osawa; Janelle Muranaka; Guillaume Stewart-Jones; Joanne Destefano; Sijy O'Dell; Celia LaBranche; James E Robinson; David C Montefiori; Krisha McKee; Sean X Du; Nicole Doria-Rose; Peter D Kwong; John R Mascola; Ping Zhu; William R Schief; Richard T Wyatt; Robert G Whalen; James M Binley
Journal:  PLoS Pathog       Date:  2015-05-29       Impact factor: 6.823

8.  HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.

Authors:  Katherine L Williams; Valerie Cortez; Adam S Dingens; Johannes S Gach; Stephanie Rainwater; Julie F Weis; Xuemin Chen; Paul Spearman; Donald N Forthal; Julie Overbaugh
Journal:  EBioMedicine       Date:  2015-10       Impact factor: 8.143

9.  Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env.

Authors:  Young Do Kwon; Marie Pancera; Priyamvada Acharya; Ivelin S Georgiev; Emma T Crooks; Jason Gorman; M Gordon Joyce; Miklos Guttman; Xiaochu Ma; Sandeep Narpala; Cinque Soto; Daniel S Terry; Yongping Yang; Tongqing Zhou; Goran Ahlsen; Robert T Bailer; Michael Chambers; Gwo-Yu Chuang; Nicole A Doria-Rose; Aliaksandr Druz; Mark A Hallen; Adam Harned; Tatsiana Kirys; Mark K Louder; Sijy O'Dell; Gilad Ofek; Keiko Osawa; Madhu Prabhakaran; Mallika Sastry; Guillaume B E Stewart-Jones; Jonathan Stuckey; Paul V Thomas; Tishina Tittley; Constance Williams; Baoshan Zhang; Hong Zhao; Zhou Zhou; Bruce R Donald; Lawrence K Lee; Susan Zolla-Pazner; Ulrich Baxa; Arne Schön; Ernesto Freire; Lawrence Shapiro; Kelly K Lee; James Arthos; James B Munro; Scott C Blanchard; Walther Mothes; James M Binley; Adrian B McDermott; John R Mascola; Peter D Kwong
Journal:  Nat Struct Mol Biol       Date:  2015-06-22       Impact factor: 15.369

10.  Peptide Triazole Thiol Irreversibly Inactivates Metastable HIV-1 Env by Accessing Conformational Triggers Intrinsic to Virus-Cell Entry.

Authors:  Charles Gotuaco Ang; Erik Carter; Ann Haftl; Shiyu Zhang; Adel A Rashad; Michele Kutzler; Cameron F Abrams; Irwin M Chaiken
Journal:  Microorganisms       Date:  2021-06-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.